Aquestive Therapeutics (AQST) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free AQST Stock Alerts $3.32 +0.23 (+7.44%) (As of 01:16 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHC Wainwright Reiterates "Buy" Rating for Aquestive Therapeutics (NASDAQ:AQST)marketbeat.com - May 9 at 8:44 AMAquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conferenceglobenewswire.com - May 9 at 8:00 AMAquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...finance.yahoo.com - May 9 at 7:49 AMAnalysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)markets.businessinsider.com - May 8 at 4:42 PMAquestive Therapeutics Inc.wsj.com - May 8 at 12:11 AMAQST Stock Earnings: Aquestive Therapeutics Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 7 at 11:03 PMAquestive Therapeutics GAAP EPS of -$0.17, revenue of $12.05Mmsn.com - May 7 at 7:11 PMAquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updateglobenewswire.com - May 7 at 4:19 PMAquestive Therapeutics (AQST) Scheduled to Post Quarterly Earnings on Tuesdayamericanbankingnews.com - May 5 at 5:52 AMAquestive Therapeutics' (AQST) Buy Rating Reaffirmed at HC Wainwrightamericanbankingnews.com - May 1 at 3:26 AMAquestive Therapeutics Earns Buy Rating on Libervant’s Pediatric Approval and Anaphylm’s Market Potentialmarkets.businessinsider.com - April 30 at 4:21 PMHC Wainwright Reaffirms "Buy" Rating for Aquestive Therapeutics (NASDAQ:AQST)marketbeat.com - April 30 at 8:35 AMAquestive stock falls amid Libervant approval, Anaphylm updatemsn.com - April 29 at 4:26 PMAquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Filmfinance.yahoo.com - April 29 at 11:25 AMBuy Rating Affirmed for Aquestive Therapeutics Following FDA Approval and Growth Prospectsmarkets.businessinsider.com - April 29 at 6:24 AMShort Interest in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Rises By 76.7%marketbeat.com - April 26 at 7:15 AMAquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ETfinance.yahoo.com - April 25 at 8:28 AMComing FDA Approvals Could Send These 3 Drug Stocks Soaringinvestorplace.com - April 17 at 8:00 AMAquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurologyglobenewswire.com - April 12 at 4:01 PMPiper starts Aquestive at overweight, cites allergy reaction treatmentmsn.com - April 11 at 5:43 PMAquestive Therapeutics a new overweight at Piper on oral film productsmsn.com - April 11 at 5:43 PMAquestive Therapeutics (NASDAQ:AQST) Coverage Initiated by Analysts at Piper Sandlermarketbeat.com - April 11 at 7:35 AMAquestive Therapeutics (NASDAQ:AQST) Receives "Buy" Rating from HC Wainwrightmarketbeat.com - April 5 at 8:20 AMRaymond James Begins Coverage on Aquestive Therapeutics (NASDAQ:AQST)marketbeat.com - March 28 at 8:28 AMAquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stockglobenewswire.com - March 25 at 8:00 AMLegato Capital Management LLC Makes New $688,000 Investment in Aquestive Therapeutics, Inc. (NASDAQ:AQST)marketbeat.com - March 25 at 6:10 AMAquestive Therapeutics slumps 13%, prices $75M offeringmsn.com - March 20 at 7:31 PMWhy Is Aquestive Therapeutics (AQST) Stock Down 14% Today?investorplace.com - March 20 at 8:46 AMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Alexander Mark Schobel Sells 50,000 Sharesinsidertrades.com - March 20 at 6:38 AMAquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stockglobenewswire.com - March 19 at 9:49 PMInsider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ...finance.yahoo.com - March 19 at 5:48 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Sells $300,000.00 in Stockmarketbeat.com - March 19 at 4:59 PMAquestive Therapeutics Announces Proposed Public Offering of Common Stockglobenewswire.com - March 19 at 4:01 PMHC Wainwright Increases Aquestive Therapeutics (NASDAQ:AQST) Price Target to $9.00marketbeat.com - March 18 at 3:11 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Sees Large Decline in Short Interestmarketbeat.com - March 18 at 12:48 AM5 Growth Stocks Under $50 for March 2024msn.com - March 15 at 1:54 PMAnalysts Conflicted on These Healthcare Names: Allogene Therapeutics (ALLO), Aquestive Therapeutics (AQST) and Allakos (ALLK)markets.businessinsider.com - March 15 at 8:53 AMAquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meetingglobenewswire.com - March 14 at 5:23 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Alexander Mark Schobel Sells 25,000 Sharesinsidertrades.com - March 13 at 7:00 AMInsider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...finance.yahoo.com - March 12 at 6:07 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Sells $129,750.00 in Stockmarketbeat.com - March 12 at 4:39 PMAquestive Therapeutics price target raised by $1 at H.C. Wainwright, here's whyrealmoney.thestreet.com - March 11 at 12:57 PMAnalysts Issue Forecasts for Aquestive Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:AQST)marketbeat.com - March 11 at 2:18 AMAquestive Therapeutics, Inc. (AQST) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 8 at 10:53 AMAquestive Therapeutics, Inc. (NASDAQ:AQST) Expected to Post Q2 2024 Earnings of ($0.08) Per Sharemarketbeat.com - March 8 at 6:50 AMAquestive Therapeutics Inc Reports Full Year 2023 Financial Resultsfinance.yahoo.com - March 7 at 6:37 PMAquestive Therapeutics price target raised by $5 at Lake Street, here's whyrealmoney.thestreet.com - March 7 at 1:37 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 7 at 1:01 PMAquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - March 7 at 8:36 AMQ4 2023 Aquestive Therapeutics Inc Earnings Callfinance.yahoo.com - March 7 at 2:03 AM Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here AQST Media Mentions By Week AQST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AQST News Sentiment▼-0.310.36▲Average Medical News Sentiment AQST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AQST Articles This Week▼82▲AQST Articles Average Week Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACIU News PBYI News ME News VSTM News IMMP News TSVT News ALDX News PYXS News XBIT News XERS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AQST) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
